We therefore surmised that a dual-specificity MAPK phosphatase, MKP-1/DUSP1, a representative mediator of dexamethasone's anti-inflammatory effects (36), could be the link between dexamethasone and the JNK pathway in CSC regulation in pancreatic cancer. Here, DUSP1 is linked to pancreatic neoplasm.